AcquisitionOther
Vincerx Pharma, Inc. acquired Vincerx Pharma, Inc. Post-closing, Oqory equity holders are expected to own approximately 95
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Vincerx Pharma, Inc. -> Vincerx Pharma, Inc. Post-closing, Oqory equity holders are expected to own approximately 95 · $13.66 million
Proposed merger would add a differentiated Phase 3 TROP2 Antibody-drug Conjugate (ADC) to the combined companys pipeline PALO ALTO, California, December 27, 2024 Vincerx Pharma, Inc .
Open source record (SEC) ↗